Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-25T05:20:23.371Z Has data issue: false hasContentIssue false
  • English
  • Français

On Flupentixol, an Antidepressant of a New Chemical Group

Published online by Cambridge University Press:  29 January 2018

Paul J. Reiter
Paul J. Reiter*
Affiliation:
Formerly Director of Psykopatanstalteme i Herstedvester. Emeritus Director of The Psychiatric Clinic, Municipal Hospital of Copenhagen
Get access Rights & Permissions [Opens in a new window]

Extract

All hitherto applied antidepressant drugs, both the tricyclic compounds and the MAO inhibitors, present serious disadvantages, not only some more or less grave undesirable side-effects, but also a rather long latency time before the antidepressant effect itself strikes through.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 115 , Issue 529 , December 1969 , pp. 1399 - 1402
Copyright
Copyright © Royal College of Psychiatrists, 1969 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Sonne, Lars Mahler (1966). Nord. psykiat. T., 20, 322–4.Google Scholar
Sonne, Lars Mahler (1967). ib., 21, 447.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.